Profile and Organisation
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. The company’s products and services are designed to benefit people and improve their quality of life. At the same time Bayer creates value through innovation, growth and high earning power.
The Group is committed to the principles of sustainable development and to its role as a socially and ethically responsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equal rank. In fiscal 2009, Bayer employed 108,400 people and had sales of €31.2 billion. Capital expenditures amounted to €1.7 billion, R&D expenses to €2.7 billion.
Organisation
Bayer AG defines common values, goals and strategies for the entire Group. The three subgroups and three service companies operate independently, led by the management holding company. The Corporate Centre supports the Group Management Board in its task of strategic leadership.
Click here to download organisation chart with management structure and fields of activity.
Business operations are the responsibility of the subgroups:
- Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products.
- Bayer CropScience, with its highly effective products, pioneering innovations and keen customer focus, holds global leadership positions in crop protection and non-agricultural pest control.
- Bayer MaterialScience is a renowned supplier of high-performance materials such as polycarbonates and polyurethanes, and innovative system solutions for a wide range of everyday uses.
Central service functions are combined into three service companies:
- Currenta offers services for the chemical industry including utility supply, waste management, infrastructure, safety, security, analytics and vocational training.
Corporate Governance
Dual governance system with the following governance bodies:
Products
The Bayer Group markets some 5,000 products. Best-sellers include:
- in the health care field: Yasmin®/YAZ®/Yasminelle®, Betaferon®/Betaseron®, Kogenate®, Adalat®, Avelox®/Avalox®
- in the nutrition field: Confidor®/ Gaucho®/Admire®/Merit®, Flint®/Stratego®/Sphere®
- in the field of high-tech materials: Makrolon®, Baydur®, Bayflex® Footwear, Desmodur®/Desmophen®
Locations
Bayer is represented around the world by 302 companies*. Global headquarters are in Leverkusen, Germany.
*fully consolidated subsidiaries (as of Dec. 31, 2009)
Workforce
On December 31, 2009, the Bayer Group had 108,400 employees worldwide (2007: 108,600). North America accounted for 16,300 of these employees, while 21,600 were based in Asia-Pacific, 16,000 in Latin America/Africa/Middle East and 54,500 in Europe. In Germany we had 36,700 employees, who made up 33.9 percent of the Group workforce.
Bayer Stock
Bayer Group Key Data
| Bayer Group |
2008
in EUR Million
|
2009
in EUR Million
|
Change
in %
|
| Net sales |
32,918
|
31,168 |
-5.3
|
| EBITDA1 |
6,266
|
5,815 |
-7.2
|
| EBITDA before special items |
6,931
|
6,472 |
-6.6
|
| EBIT2 |
3,544
|
3,006 |
-15.2
|
| EBIT before special items |
4,342
|
3,772 |
-13.1
|
| Income before income taxes |
2,356 |
1,870 |
-20.6
|
| Net income |
1,719
|
1,359 |
-20.9
|
| Earnings per share (in €)3 |
2.22
|
1.70 |
-23.4
|
| Gross cash flow4 |
5,295
|
4,658 |
-12.0
|
| Net cash flow5 |
3,608
|
5,375 |
+49.0
|
| Capital expenditures |
1,982
|
1,669 |
-15.8
|
| Research and development expenses |
2,653
|
2,746 |
+3.5
|
| Dividend per Bayer AG share (€) |
1.40
|
1.40 |
0.0
|
| |